Researchers from Sydney's Garvan Institute and the UK have developed a glow-in-the-dark 'biosensor mouse' that offers a real-time readout of the rapidly changing "skeleton" within cells.
A two-step approach has had promising results in the treatment of pancreatic cancer, which has a dismal five-year survival rate of just 7%.
One reason pancreatic cancer has a particularly low survival rate is the difficulty in getting drugs to the tumour, but new knowledge of how pancreatic cancer cells invade neighbouring cells could change that.
UNSW-led researchers have discovered that pancreatic tumours use unique genetic solutions to drive their growth, providing a new target to test tumour sensitivity to drugs.
UNSW's Minoti Apte has been honoured at the NSW Premier’s Awards for Outstanding Cancer Research for her work on pancreatic cancer.
Australian cancer researchers have developed a highly promising nanomedicine that could improve treatment for pancreatic cancer – the most deadly cancer in Australia.
A study that sequenced 100 pancreatic cancer genomes for the first time provides a new understanding of the disease’s origin and may help guide future treatment.
As a researcher working on new treatments for pancreatic cancer and the wife of a cancer survivor, Dr Phoebe Phillips knows better than most the importance of medical research.
The complexity of genetic mutations responsible for pancreatic cancer means patients may need individual diagnoses and treatments, Australian research shows.
Researchers have advanced our understanding of how cancer migrates, showing that cancer cells are accompanied by 'helper' cells when they travel in the bloodstream.